• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
    All News #Library

    Aarti Pharmalabs Yearly results, Financial Summary

    ECONOMIC TIMES

    Dayspring Pharma Reports Positive Ph II Results for CG2001 in AGA

    PR NEWSWIRE

    Once-Weekly CagriSema More Effective than Standalone Medications

    PR NEWSWIRE

    OriCell`s GPC3 CAR-T Receives NMPA Clearance for Phase II Trial

    PR NEWSWIRE

    Ascletis Showcases Obesity Portfolio and ASC30 Data at ADA 2026

    PR NEWSWIRE

    Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

    PR NEWSWIRE

    Amgen Presents Cardiometabolic Portfolio Data at ADA Sessions

    PR NEWSWIRE

    Cosylab Launches PlanOne Treatment System for Proton Therapy

    BUSINESSWIRE

    Novo`s CagriSema Cuts HbA1c and Weight in REIMAGINE at ADA

    PR NEWSWIRE

    Antengene Presents ATG-207 Preclinical Data at EULAR 2026

    PR NEWSWIRE

    Lilly`s Weight Loss Drug Shows Benefits in Menopause, Sleep Apnea

    PR NEWSWIRE

    Corcept Presents ADA Data on Korlym® in T2D with Hypercortisolism

    PRESS RELEASE

    Studies Show 1st Triple-Hormone Therapy Effective in T2D, Obesity

    FIRSTWORD PHARMA

    Oban BioPharma Presents OBT-676, First-in-Class Triple-G + DACRA

    BIOSPACE

    Henlius Doses First US Patient in Pembrolizumab Biosimilar Trial

    PRESS RELEASE

    Bio Preventive and Precision Diabetes Present DNlite at ADA 2026

    BIOSPACE

    Wegovy Pill Surpasses 3M Prescriptions as Novo Presents ADA Data

    PR NEWSWIRE

    Antag Therapeutics Presents Positive Ph 1 Data for AT7687 at ADA

    GLOBENEWSWIRE

    Survodutide Cuts Visceral Fat 34%, Liver Fat 63% in Ph III Trial

    PRESS RELEASE

    Biomea Fusion Presents Icovamenib Data and Expands BMF-650 Study

    BIOSPACE

    Ultomiris Cuts Proteinuria 43.4% vs Placebo in IgAN Ph III Trial

    PRESS RELEASE

    Uzbekistan Eyes Regional Pharma Hub, Offers Incentives to Firms

    ECONOMICTIMES

    GLP-1 Meds Linked to Fewer Heart Events in Autoimmune Patients

    PRESS RELEASE

    Verdiva Bio Presents Preclinical Obesity Drug Data at ADA 2026

    BUSINESSWIRE

    OrsoBio to Present Mitochondrial Protonophore Portfolio at ADA

    BIOSPACE

    Ultra-Long-Acting Inj GLP-1 RA Shows Weight Management Promise

    PR NEWSWIRE

    Chime Bio & Daewoong Partner on Dupilumab Biosimilar Globally

    FIRSTWORD PHARMA

    GNI Group to Acquire Ayumi Pharma, Expanding Biopharma Reach

    GLOBENEWSWIRE

    Study Proposes Rethinking How HDAC Inhibitors Work in Cancer

    PRESS RELEASE

    Lilly`s Foundayo Drives Weight Loss Across Menopause Stages

    PR NEWSWIRE

    HK Pharma Briefed on China Mainland Drug Regulation Updates

    PRESS RELEASE

    Incyte Eyes $2B Deal for Star to Grow Haematology Pipeline

    REUTERS

    Ambrosia Bio Presents Preclinical Data on AMB-702 GLP-1 RA

    BIOSPACE

    LENZ Therapeutics: Everest Acquires VIZZ Rights for China

    GLOBENEWSWIRE

    Congo says number of confirmed Ebola cases rises to 515

    REUTERS

    EU Tracks Progress Towards 2030 Clinical Trial Targets

    EMA

    Dual GLP-1/GIP Agonist for T1D Shows Promising Results

    PR NEWSWIRE

    Ebola Outbreak in DRC and Uganda Update: June 5, 2026

    CDC

    Klaria Annual Report 2025

    PRESS RELEASE

    BDCDA Warns of Improper Disposal of Expired Drugs & Medical Waste

    PHARMABIZ

    Regulator and Companies Discuss Price Hike for Some Cancer Drugs

    ECONOMICTIMES

    Semaglutide 2mg Rivals Tirzepatide in HbA1c & Weight Loss in T2D

    PR NEWSWIRE

    Novo Nordisk to Present Wegovy® Cardiometabolic Data at ADA 2026

    PR NEWSWIRE

    Roche to Start Ph 2 Petrelintide-Enicepatide Combo Trial in 2026

    ENDPOINTS

    Lilly`s Triple-G Shows Impressive Efficacy in Obesity & Diabetes

    FIERCE BIOTECH

    Telangana Cracks Down on Illegal Medical Practice in Hanamkonda

    PHARMABIZ

    Pfizer`s Berobenatide Shows Robust Ph2b Efficacy with Dosing

    BUSINESSWIRE

    PureHealth Highlights Growing Interest in Lymphatic Wellness

    PR NEWSWIRE

    Alembic Pharma Receives FDA Approval for Haloperidol Tablets

    INDPHARMAPOST

    Dexcom CONNECT Study Shows CGM Benefits in Non-Insulin T2D

    BUSINESSWIRE

    Berlin Hospital Discharges US Doctor Who Contracted Ebola

    REUTERS

    Pfizer Bets on Weight-Loss Drugs to Power Its Next Decade

    BLOOMBERG

    Dexcom CGM Shows Benefit in Non-Insulin Diabetic Patients

    REUTERS

    Cullinan Presents CLN-978 T Cell Engager Data at EULAR

    GLOBENEWSWIRE

    Abbott: Many Diabetics May Not Recognize DKA Symptoms

    PR NEWSWIRE

    SynbioTech Launches SYNMUE for Immunosenescence at Probiota

    PR NEWSWIRE

    Ractigen Presents saRNA as Obesity Treatment Frontier at ADA`26

    PR NEWSWIRE

    Novo`s Zenagamtide Achieves 14.6% Weight Loss in T2D at ADA 2026

    PR NEWSWIRE

    Grifols Backs AlphaDetect to Speed Alpha-1 Antitrypsin Detection

    PR NEWSWIRE

    Lundbeck Presents Positive Phase IIb Data for Bocunebart at AHS

    PR NEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.